Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma

SIMPLE SUMMARY: The prognosis of ovarian clear cell carcinoma was poor due to chemoresistance; therefore, immunotherapy, such as the glypican-3 (GPC3) peptide vaccine, gained attraction, as it prolonged survival. There were some super responders; however, response rates were limited because of the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukai, Mayu, Yokoi, Akira, Yoshida, Kosuke, Suzuki, Shiro, Shibata, Kiyosumi, Kikkawa, Fumitaka, Nakatsura, Tetsuya, Kajiyama, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867082/
https://www.ncbi.nlm.nih.gov/pubmed/33535558
http://dx.doi.org/10.3390/cancers13030550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867082/
https://www.ncbi.nlm.nih.gov/pubmed/33535558
http://dx.doi.org/10.3390/cancers13030550

Ejemplares similares